Old Mission Capital’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-19,772
Closed -$675K – 1504
2021
Q4
$675K Buy
+19,772
New +$774K 0.03% 549
2021
Q2
– Sell
-8,257
Closed -$398K – 1165
2021
Q1
$398K Buy
+8,257
New +$430K 0.02% 563
2020
Q3
– Sell
-11,587
Closed -$359K – 539
2020
Q2
$359K Buy
+11,587
New +$321K 0.03% 309

Other funds holding NEO

Old Mission Capital's NEO Position: Q1 2022 in Review

Old Mission Capital sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 19,772 shares — an estimated $675K sold.

Old Mission Capital first reported a position in NEO in Q2 2020 and held it in 3 quarters. The position peaked at $675K in Q4 2021. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Old Mission Capital reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Old Mission Capital sold 19,772 NeoGenomics shares in Q1 2022, an estimated $675K.
  • Old Mission Capital first reported a position in NeoGenomics in Q2 2020 and held it in 3 quarters.
  • Old Mission Capital's NeoGenomics position peaked at $675K in Q4 2021.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Old Mission Capital's 13F filing for Q1 2022, filed 13 May 2022.